169344 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
PROCESS OF PREPARING A MACROPOROUS HYDROGEL, AND IMPLEMENTATIONS THEREOF
#2DIRECT IMMUNOASSAY MEASUREMENT OF AUTOANTIBODIES
#3REAGENT COMBINATION, KIT, DETECTION SYSTEM AND DETECTION METHOD FOR DETECTING SMALL MOLECULE SUBSTANCE
#4THYROGLOBULIN QUANTITATION BY MASS SPECTROMETRY
#5BIOMARKERS FOR TREATING LIVER DISORDERS WITH THR-B AGONISTS AND RELATED USES
#6NOVEL MONOCLONAL ANTIBODIES DIRECTED AGAINST L-THYROXINE AND DIAGNOSTIC USES THEREOF
#7SYSTEMS AND METHODS FOR DETERMINING UCH-L1, GFAP, AND OTHER BIOMARKERS IN BLOOD SAMPLES
#8METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#9DEVICES AND METHODS FOR DIAGNOSISING THYROID MEDICAL CONDITIONS
#10INFORMATION PROCESSING DEVICE FOR PROVIDING REFERENCE INFORMATION RELATING TO DIAGNOSIS OF THYROID DISEASE
#11TWO PART ASSEMBLY
#12RAPID PARATHORMONE IDENTIFICATION TEST KIT
#13Thyroglobulin quantitation by mass spectrometry
#14COMPOSITIONS AND METHODS FOR TREATING PULMONARY EDEMA OR LUNG INFLAMMATION
#15METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#16Unbiased identification of tumor rejection mediating neoepitopes
#17Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#18DIRECT IMMUNOASSAY MEASUREMENT OF AUTOANTIBODIES
#19Biosensor for Diagnosis of Thyroid Dysfunction
#20Method and reagent for measuring thyroglobulin
#21Blood biomarker for discerning beta amyloid accumulation in brain
#22Improved Electrode for Electrochemical Device
#23Use of 1,25-Dihydroxyvitamin D Values in Ratio with PTH as a Prognostic Biomarker
#24Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#25Two part assembly
#26Treatment of psychiatric conditions such as resistant depression, bipolar disorder and/or major depressive disorder via application of repetitive transcranial magnetic stimulation with thyroid hormone treatment and/or quetiapine
#27BIOMARKER PREDICTING CORONARY ARTERY DISEASES
#28Method and a kit for simultaneous analyses of thyroid hormones and related metabolites in serum
#29Value assignment for customizable quality controls
#30METHOD FOR DETECTING AND QUANTIFYING VITAMINS AND THYROID ANALYTES FROM A URINE SAMPLE
#31Device for quantitative measurement of thyroid hormones
#32QUANTIFICATION OF TRANSTHYRETIN AND ITS ISOFORMS
#33High Sensitivity Measurement of Parathyroid Hormone Related Peptide Using LC-MS/MS and Associated Method
#34Thyroglobulin quantitation by mass spectrometry
#35Composition for diagnosing follicular thyroid carcinoma using expression level of aminoacyl-tRNA synthetase-related protein and method for detecting diagnostic marker
#36Antibodies to TTR and methods of use
#37Thyroglobulin quantitation by mass spectroscopy
#38COMPOSITIONS AND METHODS OF PROVIDING THYROID HORMONE OR ANALOGS THEREOF
#39Methods of detecting reverse triiodothyronine by mass spectrometry
#40QUANTITATIVE ANALYTE ASSAY DEVICE AND METHOD
#41Paramagnetic supports for use as assay reagents
#42Stabilized liquid formulations containing receptors
#43Device and method for performing a diagnostic test
#44Device and method for performing a diagnostic test
#45Method for the in vitro diagnosis of thyroid diseases
#46Value assignment for customizable quality controls
#47Thyroglobulin quantitation by mass spectroscopy
#48BIOTIN CONJUGATES OF ANALYTES CONTAINING AMINO, HYDROXYL, OR THIOL FUNCTIONAL GROUPS FOR USE IN IMMUNODIAGNOSTIC ASSAYS
#49Transgenic mouse for the assessment of thyroid hormone (TH) action
#50Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker
#51COMPOSITIONS AND METHODS OF PROVIDING THYROID HORMONE OR ANALOGS THEREOF
#52Methods of detecting reverse triiodothyronine by mass spectrometry
#53QUANTITIVE ANALYTE ASSAY DEVICE AND METHOD
#54TWO PART ASSEMBLY
#55Antibodies to TTR and Methods of Use
#56QUANTIFICATION OF TRANSTHYRETIN AND ITS ISOFORMS
#573,5,3′-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
#58OPTICAL READER SYSTEMS AND LATERAL FLOW ASSAYS
#59Anuran cross-species molecular sensors
#60Paramagnetic supports for use as assay reagents
#61High sensitivity measurement of parathyroid hormone-related peptide using LC-MS/MS and associated methods
#62Method for immunological measurement using a hapten and antibody binding to the hapten as reference antibody and device for immunological measurement using the reference antibody
#63Immunoassays employing non-particulate chemiluminescent reagent
#64Automated Assay
#65BIOTIN CONJUGATES OF ANALYTES CONTAINING AMINO, HYDROXYL, OR THIOL FUNCTIONAL GROUPS FOR USE IN IMMUNODIAGNOSTIC ASSAYS
#66TWO PART ASSEMBLY
#67Stabilized liquid formulations containing receptors
#68Methods for detecting reverse triiodothyronine by mass spectrometry
#69Value assignment for customizable quality controls
#70Thyroglobulin quantitation by mass spectroscopy
#71Thyroglobulin quantitation by mass spectrometry
#72FT4 ELECTROCHEMICAL ASSAY DETECTION SYSTEM
#73System and method for deriving parameters for homeostatic feedback control of an individual
#74Methods of detecting reverse triiodothyronine by mass spectrometry
#75Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
#76Use of antioxidants in methods and means for detection of target molecules in a blood sample
#77Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof
#78Anuran cross-species molecular sensors
#79Assay for anti-TR antibodies
#80Antibody against affinity complex
#81MEANS AND METHODS FOR ASSESSING HYPERTHYROIDISM
#82Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
#83OPTICAL READER SYSTEMS AND LATERAL FLOW ASSAYS
#84Methods for simultaneous quantification of thyroid hormones and metabolites thereof by mass spectrometry
#85QUANTIFICATION OF TRANSTHYRETIN AND ITS ISOFORMS
#86Device and method for performing a diagnostic test
#87Thyroglobulin quantitation by mass spectroscopy
#88Antibodies to TTR and methods of use
#89Thyroglobulin quantitation by mass spectrometry
#90Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#91Device and method for performing a diagnostic test
#92Diagnostic tools for charcot-marie-tooth disease
#93Methods for detecting reverse triiodothyronine by mass spectrometry
#94Thyroxine immunoassay using fluorescent particles
#95Radioiodine-Labeled Thyroxine Dosimetry, and Methods of Use Thereof
#96Liquid reagent of thyroid hormone-immobilized carrier and use thereof
#97MULTIPLE MYELOMA PROGNOSIS AND TREATMENT
#98Artificial antibody polypeptides
#99COMPOSITIONS, FORMULATIONS AND METHODS OF TREATING PREECLAMPSIA-TYPE DISORDERS OF PREGNANCY
#100Quantitative analyte assay device and method
#101Thyroglobulin quantitation by mass spectrometry
#102Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#103Methods for differentiating and monitoring parathyroid and bone status related diseases
#104IDENTIFYING PARATHYROID HORMONE AGONISTS AND ANTAGONISTS
#1053,5,3'-TRIIODOTHYRONINE SULFATE AS THYROMIMETIC AGENT AND PHARMACEUTICAL FORMULATIONS THEREOF
#106Methods and Systems for the Quantitative Analysis of Biomarkers
#107Assay for monitoring parathyroid hormone (PTH) variants by tandem mass spectrometry
#108Thyroid analyte measurement
#109Measuring multiple analytes over a broad range of concentrations using optical diffraction
#110DIAGNOSIS SYSTEM FOR DETERMINING THE BIOLOGICALLY EFFECTIVE PARATHYROID HORMONE ACTIVITY IN A SAMPLE
#111Immunoassays employing non-particulate chemiluminescent reagent
#112Method for predicting the outcome of a critically ill patient
#113Compositions and methods for improving bone mass through modulation of receptors of PTH and fragments thereof
#114Assays for nuclear hormone receptor binding
#115Detection and measurement of thyroid hormone autoantibodies
#116Thyroid analyte detection and measurement
#117Detection and measurement of thyroid analyte profile
#118Artificial antibody polypeptides
#119Biomarkers for early detection of ovarian cancer
#120BIOTINYLATED THYROXINE
#121Artificial antibody polypeptides
#122Method for the measurement of endocrine substances in an analyte
#123Diagnosis and treatment of human dormancy-related sequellae
#124Thyroglobulin quantitation by mass spectrometry
#125ELECTRODE
#126USE AND TARGETING OF CD98 LIGHT-CHAIN PROTEINS IN THERAPIES FOR THYROID HORMONE DISORDERS
#127Methods and compositions for detecting thyroglobulin in a biological sample
#128NON-NUCLEAR EFFECTS OF THYROID HORMONE
#129Use of C3a and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
#130Methods and systems for the quantitative analysis of biomarkers
#131Parathyroid hormone antagonists and uses thereof
#132Measuring thyroxine levels from dried blood samples using mass spectrometry
#133Diagnosis and treatment of human dormancy syndrome
#134Methods, kits, and antibodies for detecting parathyroid hormone
#135Methods for increasing cellular energy expenditure
#136Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor
#137Methods, kits, and antibodies for detecting parathyroid hormone
#138Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
#139Multi-analyte diagnostic test for thyroid disorders
#140Conjugates of mycophenolic acid
#141Nuclear receptor ligands and ligand binding domains
#142Parathyroid hormone antibodies and related methods
#143Artificial antibody polypeptides
#144Artificial antibody polypeptides
#145Free thyroxine and free triiodothyronine analysis by mass spectrometry
#146Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
#147Allosteric enzyme coupled immunoassay (AECIA)
#148Enabling tools to identify ligands for hormone nuclear receptors
#149Amplified cancer target genes useful in diagnosis and thereapeutic screening
#150Use of parathyroid hormone-related protein (PTHrP) in the diagnosis and treatment of chronic lung disease and other pathologies
#151Compositions and methods for detecting cyclic analogs of hPTH
#152Diagnosis and treatment of human dormancy-related sequellae
#153Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
#154Parathyroid hormone antibodies and related methods
#1553,5,3′ -triiodothronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
#156Use of parathyroid hormone-related protein(PTHRP) in the diagnosis and treatment of chronic lung disease and other pathologies
#157Tandem signaling assay
#158Methods and use of binding components for improving assay specificity
#159Methods of screening for compounds that modulate hormone receptor activity
#160Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car
#161Methods for differentiating and monitoring parathyroid and bone status related diseases
#162Conjugates of mycophenolic acid
#163Parathyroid hormone antibodies and related methods